Bessemer Securities’s Quest Diagnostics DGX Stock Holding History

Bessemer Securities’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,777	Closed	-$338K	–	38
2023 Q3	$338K	Sell	2,777 -4,215	-60%	-$562K	0.47%	81
2023 Q2	$983K	Sell	6,992 -1,400	-17%	-$193K	0.65%	56
2023 Q1	$1.19M	Buy	8,392 +700	+9%	+$100K	0.55%	73
2022 Q4	$1.2M	Hold	7,692	–	–	0.54%	71
2022 Q3	$944K	Hold	7,692	–	–	0.34%	79
2022 Q2	$1.02M	Hold	7,692	–	–	0.36%	80
2022 Q1	$1.05M	Hold	7,692	–	–	0.31%	85
2021 Q4	$1.33M	Buy	7,692 +327	+4%	+$49.8K	0.36%	77
2021 Q3	$1.07M	Hold	7,365	–	–	0.36%	77
2021 Q2	$972K	Hold	7,365	–	–	0.38%	72
2021 Q1	$945K	Buy	7,365 +4,065	+123%	+$501K	0.4%	70
2020 Q4	$393K	Hold	3,300	–	–	0.16%	66
2020 Q3	$378K	Hold	3,300	–	–	0.18%	66
2020 Q2	$376K	Hold	3,300	–	–	0.19%	65
2020 Q1	$265K	Buy	3,300 +1,650	+100%	+$171K	0.13%	85
2019 Q4	$176K	Buy	+1,650	New	+$172K	0.07%	105
2015 Q4	–	Sell	-25,009	Closed	-$1.54M	–	17
2015 Q3	$1.54M	Hold	25,009	–	–	0.59%	49
2015 Q2	$1.81M	Buy	+25,009	New	+$1.85M	0.63%	41
2014 Q1	–	Sell	-32,900	Closed	-$1.76M	–	11
2013 Q4	$1.76M	Buy	+32,900	New	+$1.95M	1.05%	27

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bessemer Securities's DGX Position: Q4 2023 in Review

Bessemer Securities sold out of Quest Diagnostics (DGX) in Q4 2023, closing a stake of 2,777 shares — an estimated $338K sold.

Bessemer Securities first reported a position in DGX in Q4 2013 and held it in 19 quarters. The position peaked at $1.81M in Q2 2015. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

Bessemer Securities reported no remaining Quest Diagnostics position as of Q4 2023 after selling out during the quarter.
Bessemer Securities sold 2,777 Quest Diagnostics shares in Q4 2023, an estimated $338K.
Bessemer Securities first reported a position in Quest Diagnostics in Q4 2013 and held it in 19 quarters.
Bessemer Securities's Quest Diagnostics position peaked at $1.81M in Q2 2015.
826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on Bessemer Securities's 13F filing for Q4 2023.